Fei Peng1, Si Lei1, Quan Zhang1, Yanjun Zhong2, Shangjie Wu1. 1. Department of Respiratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, China. 2. Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
Abstract
BACKGROUND: Cigarette smoking has been proven to be a risk factor in the development of many diseases. However, it remains controversial with respect to the relationship of smoking with COVID-19. The purpose of this study was to explore the role of smoking in COVID-19. METHODS: A total of 622 patients with COVID-19 in China were enrolled in the study. Corresponding clinical and laboratory data were collected and analyzed. Meanwhile, Kaplan-Meier curve and Cox regression analysis were employed to analyze the association of smoking with survival in patients with COVID-19. RESULTS: Smoking was statistically significant comparing non-survivors and survivors of patients with COVID-19 (P = 0.007). Males had higher proportion of smoking than females (91.9% vs. 8.1%, P < 0.001). Compared with the non-smoker, there was significant statistical difference in the incidence of cerebrovascular disease in smoking patients with COVID-19 (9.7% vs. 3.4%, P = 0.017). White blood cell count (6.3 vs. 5.4; P = 0.037), hemoglobin level (139.0 vs. 127.0; P < 0.001), and creatinine level (77.3 vs. 61.0; P < 0.001) were significantly increased in COVID-19 patients who smoked. Moreover, smoking patients showed a worse survival compared with non-smoking patients (Log Rank P = 0.045). After adjustment for age, gender and underlying diseases, patients with smoking still had higher risk of mortality than that of non-smoking patients (hazard ratio[HR] 1.897, 95% confidence interval [CI]1.058-3.402, P = 0.032). CONCLUSION: Smoking was thought to be a risk factor in predicting the prognosis of COVID-19 and smoking patients might have a higher risk of mortality than that of the non-smoking patients.
BACKGROUND: Cigarette smoking has been proven to be a risk factor in the development of many diseases. However, it remains controversial with respect to the relationship of smoking with COVID-19. The purpose of this study was to explore the role of smoking in COVID-19. METHODS: A total of 622 patients with COVID-19 in China were enrolled in the study. Corresponding clinical and laboratory data were collected and analyzed. Meanwhile, Kaplan-Meier curve and Cox regression analysis were employed to analyze the association of smoking with survival in patients with COVID-19. RESULTS: Smoking was statistically significant comparing non-survivors and survivors of patients with COVID-19 (P = 0.007). Males had higher proportion of smoking than females (91.9% vs. 8.1%, P < 0.001). Compared with the non-smoker, there was significant statistical difference in the incidence of cerebrovascular disease in smoking patients with COVID-19 (9.7% vs. 3.4%, P = 0.017). White blood cell count (6.3 vs. 5.4; P = 0.037), hemoglobin level (139.0 vs. 127.0; P < 0.001), and creatinine level (77.3 vs. 61.0; P < 0.001) were significantly increased in COVID-19 patients who smoked. Moreover, smoking patients showed a worse survival compared with non-smoking patients (Log Rank P = 0.045). After adjustment for age, gender and underlying diseases, patients with smoking still had higher risk of mortality than that of non-smoking patients (hazard ratio[HR] 1.897, 95% confidence interval [CI]1.058-3.402, P = 0.032). CONCLUSION: Smoking was thought to be a risk factor in predicting the prognosis of COVID-19 and smoking patients might have a higher risk of mortality than that of the non-smoking patients.
Authors: Iziah E Sama; Alice Ravera; Bernadet T Santema; Harry van Goor; Jozine M Ter Maaten; John G F Cleland; Michiel Rienstra; Alex W Friedrich; Nilesh J Samani; Leong L Ng; Kenneth Dickstein; Chim C Lang; Gerasimos Filippatos; Stefan D Anker; Piotr Ponikowski; Marco Metra; Dirk J van Veldhuisen; Adriaan A Voors Journal: Eur Heart J Date: 2020-05-14 Impact factor: 29.983
Authors: Joan C Smith; Erin L Sausville; Vishruth Girish; Monet Lou Yuan; Anand Vasudevan; Kristen M John; Jason M Sheltzer Journal: Dev Cell Date: 2020-05-16 Impact factor: 12.270
Authors: Janet Diaz-Martinez; Ivan Delgado-Enciso; Adriana Campa; Javier A Tamargo; Haley R Martin; Angelique Johnson; Suzanne Siminski; Pamina M Gorbach; Marianna K Baum Journal: Int J Environ Res Public Health Date: 2022-07-05 Impact factor: 4.614
Authors: Frank R Wendt; Antonella De Lillo; Gita A Pathak; Flavio De Angelis; Renato Polimanti Journal: Front Genet Date: 2021-12-13 Impact factor: 4.599
Authors: Kristina L Bailey; Harlan Sayles; James Campbell; Neha Khalid; Madyson Anglim; Jana Ponce; Todd A Wyatt; James C McClay; Ellen L Burnham; Alfred Anzalone; Corrine Hanson Journal: Alcohol Clin Exp Res Date: 2022-05-02 Impact factor: 3.928
Authors: Abbas Hoballah; Rana El Haidari; Rima Badran; Ali Jaber; Samir Mansour; Linda Abou-Abbas Journal: BMC Infect Dis Date: 2022-09-24 Impact factor: 3.667
Authors: Jing Yang; Edith A Perez; Changchun Hou; Pin Zhang; Michelle Van Scoyk; Robert A Winn; Lijun Rong; Jing Liu Journal: Front Immunol Date: 2021-07-07 Impact factor: 7.561